Description:
AG-879, a tyrphostin compound, is a dual EGFR/HER2 inhibitor that was administered together with androgen withdrawal therapy. It inhibits nerve growth factor (NGF)-dependent TrkA tyrosine phosphorylation in PC-12 cells (IC50 = ~40 μM), HER2-ErbB2 kinase in several breast and ovarian cancer cell lines (IC50 = ~0.5 μM), and the VEGF receptor FLK1 (IC50 = ~1 μM).
Molecular Formula:
C18H24N2OS
Canonical SMILES:
CC(C)(C)C1=CC(=CC(=C(N)S)C#N)C=C(C1=O)C(C)(C)C
InChI:
InChI=1S/C18H24N2OS/c1-17(2,3)13-8-11(7-12(10-19)16(20)22)9-14(15(13)21)18(4,5)6/h7-9,22H,20H2,1-6H3/b16-12+
InChIKey:
LCUMYVYIHXYBIA-FOWTUZBSSA-N
Solubility:
DMSO to 100 mM; ethanol to 25 mM
Appearance:
Yellow solid
Synonyms:
α-Cyano-(3,5-di-t-butyl-4-hydroxy)thiocinnamide Más detalles se encuentran
aquí